Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/126130
Title: | Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis |
Author: | García Bermúdez, Mercedes López Mejías, Raquel González Juanatey, Carlos Castañeda, Santos Miranda-Filloy, José A. Blanco, Ricardo Fernández Gutiérrez, Benjamín Balsa, Alejandro González Álvaro, Isidoro Gómez Vaquero, Carmen Llorca Díaz, Javier Martín, Javier González-Gay, Miguel A. |
Keywords: | Artritis reumatoide Malalties cardiovasculars Marcadors genètics Complicacions (Medicina) Rheumatoid arthritis Cardiovascular diseases Genetic markers Complications (Medicine) |
Issue Date: | 1-Jul-2012 |
Publisher: | Mary Ann Liebert |
Abstract: | Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular (CV) mortality. Toll-like receptor-4 (TLR4) activates the innate immune response via NF-kB pathway and mitogen-activated protein kinase signaling, leading to expression of proinflammatory cytokines and chemokines. The G allele of TLR4 rs4986790 (+896A > G, Asp299Gly) gene polymorphism has been implicated in reduction of risk of atherosclerosis. In this study, 1481 RA patients fulfilling the 1987 American College of Rheumatology (ACR) criteria were genotyped for the rs4986790 TLR4 variant to determine the influence of this variant in the risk of CV events in these patients. Also, HLA-DRB1 status was determined using molecular based methods. Moreover, potential influence of rs4986790 variant in the development of subclinical atherosclerosis was assessed in a subgroup of RA patients with no history of CV events by the measurement of surrogate markers of subclinical atherosclerosis. No statistically significant differences in allele or genotype frequencies for the rs4986790 variant between RA patients who experienced CV events or not were found. Likewise, no significant association between this gene variant and any of the surrogate markers of subclinical atherosclerosis was found. In summary, results in our study do not support the hypothesis that the rs4986790 (+896A > G, Asp299Gly) TLR4 variant may influence predisposition for subclinical atherosclerosis and clinically evident CV disease in RA patients. |
Note: | Reproducció del document publicat a: https://doi.org/10.1089/dna.2011.1582 |
It is part of: | DNA and Cell Biology, 2012, vol. 31, num. 7, p. 1214-1220 |
URI: | http://hdl.handle.net/2445/126130 |
Related resource: | https://doi.org/10.1089/dna.2011.1582 |
ISSN: | 1044-5498 |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
649743.pdf | 155.35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.